BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 25322784)

  • 1. Recent developments in urinalysis of metabolites of new psychoactive substances using LC-MS.
    Peters FT
    Bioanalysis; 2014 Aug; 6(15):2083-107. PubMed ID: 25322784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid chromatography-tandem mass spectrometry screening method using information-dependent acquisition of enhanced product ion mass spectra for synthetic cannabinoids including metabolites in urine.
    Staeheli SN; Veloso VP; Bovens M; Bissig C; Kraemer T; Poetzsch M
    Drug Test Anal; 2019 Sep; 11(9):1369-1376. PubMed ID: 31219237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS.
    Caspar AT; Helfer AG; Michely JA; Auwärter V; Brandt SD; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2015 Sep; 407(22):6697-719. PubMed ID: 26108532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening power with further MS techniques.
    Caspar AT; Westphal F; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2018 Jan; 410(3):897-912. PubMed ID: 28762065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures.
    Wagmann L; Richter LHJ; Kehl T; Wack F; Bergstrand MP; Brandt SD; Stratford A; Maurer HH; Meyer MR
    Anal Bioanal Chem; 2019 Jul; 411(19):4751-4763. PubMed ID: 30617391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of anonymous pooled urine from portable urinals in central London confirms the significant use of novel psychoactive substances.
    Archer JR; Dargan PI; Hudson S; Wood DM
    QJM; 2013 Feb; 106(2):147-52. PubMed ID: 23178933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of LC-MS/MS in hair testing for the determination of common drugs of abuse and other psychoactive drugs.
    Vincenti M; Salomone A; Gerace E; Pirro V
    Bioanalysis; 2013 Aug; 5(15):1919-38. PubMed ID: 23905865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for urine drug testing using one-step dilution and direct injection in combination with LC-MS/MS and LC-HRMS.
    Beck O; Ericsson M
    Bioanalysis; 2014 Aug; 6(17):2229-44. PubMed ID: 25383734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple and rapid screening procedure for 143 new psychoactive substances by liquid chromatography-tandem mass spectrometry.
    Adamowicz P; Tokarczyk B
    Drug Test Anal; 2016 Jul; 8(7):652-67. PubMed ID: 25976069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MS
    Caspar AT; Gaab JB; Michely JA; Brandt SD; Meyer MR; Maurer HH
    Drug Test Anal; 2018 Jan; 10(1):184-195. PubMed ID: 28342193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology - An update.
    Remane D; Wissenbach DK; Peters FT
    Clin Biochem; 2016 Sep; 49(13-14):1051-71. PubMed ID: 27452180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergency department visits due to new psychoactive substances and other illicit drugs in Taiwan: preliminary results of the Taiwan Emergency Department Drug Abuse Surveillance (TEDAS) project.
    Lin CC; Weng TI; Ng CJ; Shih CP; Hsu J; Liao YC; Yang CC; Fang CC;
    Clin Toxicol (Phila); 2022 Jun; 60(6):708-715. PubMed ID: 35315299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and quantification of 56 new psychoactive substances in whole blood and urine by LC-MS/MS.
    Ambach L; Redondo AH; König S; Angerer V; Schürch S; Weinmann W
    Bioanalysis; 2015; 7(9):1119-36. PubMed ID: 26039809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Benefits of Direct-to-Definitive Testing for Monitoring Compliance in Pain Management.
    Gencheva R; Petrides A; Kantartjis M; Tanasijevic M; Dahlin JL; Melanson S
    Pain Physician; 2018 Nov; 21(6):E583-E592. PubMed ID: 30508989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry.
    Vikingsson S; Gréen H; Brinkhagen L; Mukhtar S; Josefsson M
    Drug Test Anal; 2016 Sep; 8(9):950-6. PubMed ID: 26560240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated analysis of dried urine spot (DUS) samples for toxicology screening.
    Pablo A; Breaud AR; Clarke W
    Clin Biochem; 2020 Jan; 75():70-77. PubMed ID: 31707014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A data-independent acquisition workflow for qualitative screening of new psychoactive substances in biological samples.
    Kinyua J; Negreira N; Ibáñez M; Bijlsma L; Hernández F; Covaci A; van Nuijs AL
    Anal Bioanal Chem; 2015 Nov; 407(29):8773-85. PubMed ID: 26396082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a clinically relevant liquid chromatography tandem mass spectrometry assay for 13 drugs of abuse in urine, designed to meet the needs of the service users.
    Duxbury K; Romagnoli C; Anderson M; Watts R; Waite G
    Ann Clin Biochem; 2010 Sep; 47(Pt 5):415-22. PubMed ID: 20595401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting human urinary metabolome by LC-MS/MS: a review.
    Rodríguez-Morató J; Pozo ÓJ; Marcos J
    Bioanalysis; 2018 Apr; 10(7):489-516. PubMed ID: 29561651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.